CA2235148A1 - Novel dnas and process for producing proteins by using the same - Google Patents

Novel dnas and process for producing proteins by using the same Download PDF

Info

Publication number
CA2235148A1
CA2235148A1 CA002235148A CA2235148A CA2235148A1 CA 2235148 A1 CA2235148 A1 CA 2235148A1 CA 002235148 A CA002235148 A CA 002235148A CA 2235148 A CA2235148 A CA 2235148A CA 2235148 A1 CA2235148 A1 CA 2235148A1
Authority
CA
Canada
Prior art keywords
dna
sequence
ocif
protein
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002235148A
Other languages
English (en)
French (fr)
Inventor
Hisataka Yasuda
Tomonori Morinaga
Nobuaki Nakagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2235148A1 publication Critical patent/CA2235148A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002235148A 1996-08-19 1997-08-19 Novel dnas and process for producing proteins by using the same Abandoned CA2235148A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8235928A JPH1057071A (ja) 1996-08-19 1996-08-19 新規ｄｎａ及びそれを用いた蛋白質の製造方法
JP235928/1996 1996-08-19

Publications (1)

Publication Number Publication Date
CA2235148A1 true CA2235148A1 (en) 1998-02-26

Family

ID=16993321

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002235148A Abandoned CA2235148A1 (en) 1996-08-19 1997-08-19 Novel dnas and process for producing proteins by using the same

Country Status (12)

Country Link
EP (1) EP0874045A1 (enExample)
JP (1) JPH1057071A (enExample)
KR (1) KR20000064276A (enExample)
CN (1) CN1198776A (enExample)
AU (1) AU718458B2 (enExample)
CA (1) CA2235148A1 (enExample)
FI (1) FI980853L (enExample)
HU (1) HUP0001837A3 (enExample)
NO (1) NO981748L (enExample)
NZ (1) NZ330400A (enExample)
WO (1) WO1998007840A1 (enExample)
ZA (1) ZA977402B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919434B1 (en) 1995-02-20 2005-07-19 Sankyo Co., Ltd. Monoclonal antibodies that bind OCIF
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
WO1998028424A2 (en) 1996-12-23 1998-07-02 Immunex Corporation Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
ATE328006T1 (de) 1997-04-15 2006-06-15 Sankyo Co Neues protein und verfahren zu dessen herstellung
PL190092B1 (pl) 1997-04-16 2005-10-31 Amgen Inc Proteiny wiążące osteoprotegerynę oraz ich receptory
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
RU2203497C2 (ru) 1997-09-24 2003-04-27 Санкио Компани Лимитед Способ диагностики метаболических костных заболеваний
JP2002514418A (ja) 1998-05-14 2002-05-21 イミュネックス・コーポレーション 破骨細胞活性の阻害方法
AU755422B2 (en) 1998-10-28 2002-12-12 Sankyo Company Limited Remedies for bone metabolic errors
AUPQ167599A0 (en) * 1999-07-19 1999-08-12 St. Vincent's Institute Of Medical Research Inhibitor of osteoclast precursor formation
AU7720600A (en) * 1999-09-27 2001-04-30 Eli Lilly And Company Osteoprotegerin regulatory region
DE60235418D1 (de) 2001-04-03 2010-04-01 Nestle Sa Osteoprotegerin in Milch
AU2002309647C1 (en) 2001-05-25 2008-09-11 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to trail receptors
EP1494714A4 (en) 2002-04-05 2008-03-05 Amgen Inc HUMAN ANTI-OPGL NEUTRALIZING ANTIBODIES AS SELECTIVE OPGL PATH HEMMER

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin

Also Published As

Publication number Publication date
FI980853A7 (fi) 1998-06-15
EP0874045A1 (en) 1998-10-28
FI980853L (fi) 1998-06-15
HUP0001837A3 (en) 2002-09-30
NZ330400A (en) 1999-05-28
EP0874045A4 (enExample) 1998-11-18
HUP0001837A2 (hu) 2000-09-28
MX9803086A (es) 1998-11-29
ZA977402B (en) 1999-02-18
FI980853A0 (fi) 1998-04-17
AU718458B2 (en) 2000-04-13
NO981748L (no) 1998-06-18
JPH1057071A (ja) 1998-03-03
CN1198776A (zh) 1998-11-11
NO981748D0 (no) 1998-04-17
WO1998007840A1 (fr) 1998-02-26
KR20000064276A (ko) 2000-11-06
AU3866197A (en) 1998-05-11

Similar Documents

Publication Publication Date Title
AU650893B2 (en) O-glycosylated alpha-2 interferon
US6337387B1 (en) Differentiation-suppressive polypeptide
US6664098B1 (en) Differentiation inhibitory agent
CA2235148A1 (en) Novel dnas and process for producing proteins by using the same
JP4216343B2 (ja) 哺乳類サイトカイン様因子７
CA2145778A1 (en) Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
CA2226087A1 (en) Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
EA005581B1 (ru) ПОЛИПЕПТИДЫ ЦИТОКИНА Zcyto10 ЧЕЛОВЕКА И МЫШИ, КОДИРУЮЩИЕ ИХ ПОЛИНУКЛЕОТИДЫ И АНТИТЕЛА К УКАЗАННЫМ ПОЛИПЕПТИДАМ
WO1994001557A1 (en) Bone formation-inducing protein
CA2181431A1 (en) Haemopoietic maturation factor
WO1997000317A1 (en) Osteoclast growth regulatory factor
US7414024B2 (en) Proteins with IL-6 inhibiting activity
US6338949B1 (en) Nucleic acids encoding receptor recognition factor stat4 and methods of use thereof
AU712852B2 (en) Use of an "immunodeficiency-virus suppressing lymphokine (ISL)" to inhibit the replication of viruses, in particular of retroviruses
US20020068288A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US20020065394A1 (en) Secreted proteins and polynucleotides encoding them
US20040248787A1 (en) Cell death inducers for mast cells
WO1999055863A1 (fr) Nouveau polypeptide, adnc le codant et son utilisation
US20030040476A1 (en) EAG gene
US6605442B1 (en) Methods of testing drugs or agents that modulate the activity of receptor recognition factors
MXPA98003086A (en) Novel dnas and process for producing proteins by using the same
US20020123619A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US20030008356A1 (en) Novel polypeptide, a cDNA encoding the same, and use of it
TW202229554A (zh) 用於降低血管收縮素轉化酶２（ａｃｅ２）之表現的寡核苷酸及其用於治療病毒感染的用途
EP1192181B1 (en) Modulation of angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor for the treatment of tumor

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued